NCT04903145

Brief Summary

(i) To validate the inversed occlusion technique by comparing the results of resistance obtained on the relaxed expiratory occlusion monitor (REOM) with the resistance obtained with respiratory oscillometry (OSC) measurements on the tremoflo® C-100 and (ii) explore (within-test and day-to-day) repeatability and responsiveness to change of this technique when used as home monitoring device in children with asthma.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 26, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

May 27, 2021

Status Verified

May 1, 2021

Enrollment Period

11 months

First QC Date

May 19, 2021

Last Update Submit

May 25, 2021

Conditions

Keywords

tremoflooscillometryinterrupterasthmaREOM

Outcome Measures

Primary Outcomes (3)

  • Respiratory resistance R5

    Using the tremoflo C-100 at 5 Hz to calculate the mean resistance during the patient's tidal breathing.

    Over one week

  • Expiratory resistance (R5exp)

    Using the tremoflo C-100 at 5 Hz to calculate resistance during the patient's exhalation.

    Over one week

  • Resistance at low expiratory flow (Reo2)

    Using the REOM device the resistance (Reo2) at low expiratory flow will be calculated.

    Over one week

Secondary Outcomes (3)

  • Respiratory resistance R19

    Over one week

  • Expiratory resistance (R19exp)

    Over one week

  • Resistance at high expiratory flow (Reo1)

    Over one week

Interventions

REOMDIAGNOSTIC_TEST

To compare data generated by the REOM device with data from the tremoflo C-100 device

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The asthmatic study subjects will be recruited a the Sainte-Justine University Hospital Center, Montreal, QC. Recruitment will be performed by Dr. Ducharme's research staff. The study will be conducted remotely with patients who consented to the Pediatric asthma database and Biobank of the Sainte-Justine University Hospital Center or among the families subscribing to the Asthma Clinic newsletter or seeing the advertisement on the CHUSJ website.

You may qualify if:

  • Children aged between 6 and 17 years old
  • Adequate understanding of French or English
  • Asthma diagnosis confirmed by a physician
  • Poor asthma control in the past 6 months, that is,
  • an acute exacerbation requiring oral corticosteroids, or
  • an FEV1 \<80% of predicted, FEV1/FVC ratio below the lower limit of normal, or significant (≥12%) reversibility in FEV1, or
  • a total score \<20 on the child Asthma Control Test (ACT) for children aged ≤11 years or on the ACT for those aged ≥12 years).

You may not qualify if:

  • Inability to produce a good seal around the mouthpiece when previously tested with spirometry
  • Oscillometry or REOM, contra-indication to performing respiratory tests (e.g., facial trauma, chest pain, severe scoliosis)
  • Other reason interfering with respiratory testing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sainte-Justine University Hospital Center

Montreal, Quebec, H3T 1C5, Canada

Location

Related Publications (15)

  • Kaminsky DA. What does airway resistance tell us about lung function? Respir Care. 2012 Jan;57(1):85-96; discussion 96-9. doi: 10.4187/respcare.01411.

    PMID: 22222128BACKGROUND
  • Lamontagne AJ, Pelaez S, Grad R, Blais L, Lavoie KL, Bacon SL, Guay H, Gauthier A, McKinney ML, Ernst P, Collin J, Ducharme FM. Facilitators and solutions for practicing optimal guided asthma self-management: the physician perspective. Can Respir J. 2013 Jul-Aug;20(4):285-93. doi: 10.1155/2013/146839.

    PMID: 23936888BACKGROUND
  • Kaplan A, Stanbrook M. Must family physicians use spirometry in managing asthma patients?: YES. Can Fam Physician. 2010 Feb;56(2):126, 128, 130,132; discussion e49, e51. No abstract available.

    PMID: 20154239BACKGROUND
  • Lundblad LKA, Blouin N, Grudin O, Grudina L, Drapeau G, Restrepo N, Ducharme FM. Comparing lung oscillometry with a novel, portable flow interrupter device to measure lung mechanics. J Appl Physiol (1985). 2021 Apr 1;130(4):933-940. doi: 10.1152/japplphysiol.01072.2020. Epub 2021 Feb 4.

    PMID: 33539262BACKGROUND
  • Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, Fitzgerald M, Leigh R, Watson W, Boulet LP; Canadian Thoracic Society Asthma Clinical Assembly. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J. 2012 Mar-Apr;19(2):127-64. doi: 10.1155/2012/635624.

    PMID: 22536582BACKGROUND
  • Bates JH, Irvin CG, Farre R, Hantos Z. Oscillation mechanics of the respiratory system. Compr Physiol. 2011 Jul;1(3):1233-72. doi: 10.1002/cphy.c100058.

    PMID: 23733641BACKGROUND
  • Goldman MD, Saadeh C, Ross D. Clinical applications of forced oscillation to assess peripheral airway function. Respir Physiol Neurobiol. 2005 Aug 25;148(1-2):179-94. doi: 10.1016/j.resp.2005.05.026.

    PMID: 15990365BACKGROUND
  • MEAD J, WHITTENBERGER JL. Evaluation of airway interruption technique as a method for measuring pulmonary airflow resistance. J Appl Physiol. 1954 Jan;6(7):408-16. doi: 10.1152/jappl.1954.6.7.408. No abstract available.

    PMID: 13117773BACKGROUND
  • Ducharme FM, Jroundi I, Jean G, Lavoie Boutin G, Lawson C, Vinet B. Interdevice agreement in respiratory resistance values by oscillometry in asthmatic children. ERJ Open Res. 2019 Mar 18;5(1):00138-2018. doi: 10.1183/23120541.00138-2018. eCollection 2019 Feb.

    PMID: 30895187BACKGROUND
  • Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, Marchal F; ERS Task Force on Respiratory Impedance Measurements. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003 Dec;22(6):1026-41. doi: 10.1183/09031936.03.00089403.

    PMID: 14680096BACKGROUND
  • Jones SR, Carley S, Harrison M. An introduction to power and sample size estimation. Emerg Med J. 2003 Sep;20(5):453-8. doi: 10.1136/emj.20.5.453.

    PMID: 12954688BACKGROUND
  • Shi Y, Aledia AS, Tatavoosian AV, Vijayalakshmi S, Galant SP, George SC. Relating small airways to asthma control by using impulse oscillometry in children. J Allergy Clin Immunol. 2012 Mar;129(3):671-8. doi: 10.1016/j.jaci.2011.11.002. Epub 2011 Dec 17.

    PMID: 22178635BACKGROUND
  • Robinson PD, Brown NJ, Turner M, Van Asperen P, Selvadurai H, King GG. Increased day-to-day variability of forced oscillatory resistance in poorly controlled or persistent pediatric asthma. Chest. 2014 Oct;146(4):974-981. doi: 10.1378/chest.14-0288.

    PMID: 24991854BACKGROUND
  • Wong A, Hardaker K, Field P, Huvanandana J, King GG, Reddel H, Selvadurai H, Thamrin C, Robinson PD. Home-based Forced Oscillation Technique Day-to-Day Variability in Pediatric Asthma. Am J Respir Crit Care Med. 2019 May 1;199(9):1156-1160. doi: 10.1164/rccm.201809-1659LE. No abstract available.

    PMID: 30822109BACKGROUND
  • Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol. 1992 Dec;45(12):1341-5. doi: 10.1016/0895-4356(92)90194-r.

    PMID: 1460470BACKGROUND

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Francine M Ducharme, MD

    St. Justine's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Francine M Ducharme, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2021

First Posted

May 26, 2021

Study Start

June 1, 2021

Primary Completion

May 1, 2022

Study Completion

October 1, 2022

Last Updated

May 27, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations